OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Research progress on multiple cell death pathways of podocytes in diabetic kidney disease
Can Yang, Zhen Zhang, Jieting Liu, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 22

Showing 22 citing articles:

Exosomes derived from mesenchymal stem cells in diabetes and diabetic complications
Yurui Jiao, Kaixuan Chen, Xiang Tang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 18

Targeting the NF-κB p65-MMP28 axis: Wogonoside as a novel therapeutic agent for attenuating podocyte injury in diabetic nephropathy
Xiandeng Li, Shuyan Zhao, Jing Xie, et al.
Phytomedicine (2025) Vol. 138, pp. 156406-156406
Open Access | Times Cited: 2

Lipid metabolism disorder in diabetic kidney disease
Yi-Zhen Han, Bo-Xuan Du, Xingyu Zhu, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 9

Biomedicine and pharmacotherapeutic effectiveness of combinatorial atorvastatin and quercetin on diabetic nephropathy: An in vitro study
Haleema Shahin DH, Rokeya Sultana, Ashwini Prabhu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116533-116533
Open Access | Times Cited: 8

Boeravinone C ameliorates lipid accumulation and inflammation in diabetic kidney disease by activating PPARα signaling
Zhuoqing Cheng, Honghong Zhan, Han Yuan, et al.
Journal of Ethnopharmacology (2025), pp. 119398-119398
Closed Access

Hirsutine Mitigates Ferroptosis in Podocytes of Diabetic Kidney Disease by Downregulating the p53/GPX4 Signaling Pathway
Zhenzhen Pei, Yupeng Chen, Yang Zhang, et al.
European Journal of Pharmacology (2025), pp. 177289-177289
Closed Access

From fat to filter: the effect of adipose tissue-derived signals on kidney function
Nermin Ahmed, C. Dalmasso, M. Turner, et al.
Nature Reviews Nephrology (2025)
Closed Access

Targeting endoplasmic reticulum stress: an innovative therapeutic strategy for podocyte-related kidney diseases
Jiao Lv, Haiying Yu, Shaojun Du, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access

Klotho antiaging protein: molecular mechanisms and therapeutic potential in diseases
Aditya Dipakrao Hajare, Neha Dagar, Anil Bhanudas Gaikwad
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access

Triptolide Attenuates Renal Slit Diagram to Tight Junction Transition in Diabetic Kidney Disease by Regulating Nrf2–Ferroptosis Pathway
H Wang, Hai-Xia Wu, Weiqing Shi, et al.
The American Journal of Chinese Medicine (2024) Vol. 52, Iss. 07, pp. 2161-2185
Closed Access | Times Cited: 2

Tangshen formula protects against podocyte apoptosis via enhancing the TFEB-mediated autophagy-lysosome pathway in diabetic nephropathy
Yuyang Wang, Liang Peng, Xiaoguang Lu, et al.
Journal of Ethnopharmacology (2024) Vol. 324, pp. 117721-117721
Closed Access | Times Cited: 1

Activation of Protein Kinase B Rescues against Thapsigargin-Elicited Cardiac Dysfunction through Regulation of NADPH Oxidase and Ferroptosis
Xiaohu Wang, Fengjuan Li, Yong Cheng, et al.
Chemico-Biological Interactions (2024), pp. 111292-111292
Closed Access | Times Cited: 1

Targeting programmed cell death in diabetic kidney disease: from molecular mechanisms to pharmacotherapy
Fengzhao Liu, Zhenyu Yang, Jixin Li, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 1

Podocyte injury and death: New insights into lupus nephritis pathogenesis and therapy
Xiaolei Shi, Zhipeng Wang, Ruihan Tang, et al.
Rheumatology & autoimmunity (2023) Vol. 3, Iss. 4, pp. 193-204
Open Access | Times Cited: 3

Research progress on Alpinia oxyphylla in the treatment of diabetic nephropathy
Jing Wang, Xiaomin Wang, Tianpeng Ma, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access

HNRNP I promotes IRAK1 degradation to reduce podocyte apoptosis and inflammatory response alleviating renal injury in diabetic nephropathy
Zichen Rao, Geriletu Ao, Yiming Zhang, et al.
Immunobiology (2024) Vol. 229, Iss. 5, pp. 152835-152835
Open Access

Quercetin‐4′‐O‐β‐D‐glucopyranoside inhibits podocyte injury by SIRT5‐mediated desuccinylation of NEK7
Menghua Wu, Xiaoli Ye
Clinical and Experimental Pharmacology and Physiology (2024) Vol. 51, Iss. 9
Closed Access

Jiawei Wumei Wan alleviates renal fibrosis in diabetic nephropathy mice by regulating the PI3K/AKT/mTOR signaling pathway
Yijun Pi, Xu Huang, Chengji Cui, et al.
CHINESE JOURNAL OF ANALYTICAL CHEMISTRY (CHINESE VERSION) (2024), pp. 100446-100446
Open Access

Page 1

Scroll to top